Articles
29 May 2009
Vol. 1 No. 5: International Symposium on Infection-Driven Lymphomas, Rome, April 17-19, 2005
https://doi.org/10.4081/hmr.v1i5.256

The use of purine analogues and infections

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
160
Views
756
Downloads

Authors

Annamaria Nosari
support@pagepress.org
In the 1980s, the purine analogues chemotherapy agents, fludarabine, deoxycoformycin, chlorodeoxyadenosine, were introduced into clinical usage for the care of patients with a variety of hematologic malignancies. These drugs have been mainly used in indolent lymphoproliferative neoplasms with effective hematologic responses, but they have been accompanied by a different spectrum of infections because of selective T-cell abnormalities which these agents determine.

Altmetrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



The use of purine analogues and infections. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.256